...
首页> 外文期刊>Journal of chemotherapy >Risk factors for colonization with ampicillin and high-level aminoglycoside-resistant enterococci during hospitalization in the ICU and the impact of prior antimicrobial exposure definition: A prospective cohort study
【24h】

Risk factors for colonization with ampicillin and high-level aminoglycoside-resistant enterococci during hospitalization in the ICU and the impact of prior antimicrobial exposure definition: A prospective cohort study

机译:ICU住院期间氨苄西林和高水平对氨基糖苷类耐药的肠球菌定植的危险因素以及先前抗菌药物暴露定义的影响:一项前瞻性队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of our prospective cohort study was to determine the incidence, genetic relatedness and risk factors for colonization with ampicillin and high-level aminoglycoside-resistant enterococci (ARHLARE) among patients hospitalized in the intensive care unit. During 15-month period, we included 105 patients. The only independent risk factor for ARHLARE colonization was days of cefotaxime/ceftriaxone therapy [odds ratio (OR): 1.13; 95% confidence interval (CI) 1.10-1.27; P = 0.045]. Patients with higher total use of antibiotics, patients on prolonged mechanical ventilation, and patients with urinary tract infection (UTI), were also found to be at increased risk to become colonized with ARHLARE. Pulsed-field gel electrophoresis suggested multifocal origin of the majority of the colonizing strains. Our results show that an increase in total antibiotic consumption for 10 defined daily doses (DDD)/patient increased the odds of colonization with ARHLARE for 36%. Further efforts to optimize antimicrobial use in high risk patients are proposed.
机译:我们的前瞻性队列研究旨在确定在重症监护病房住院的患者中氨苄西林和高水平氨基糖苷耐药性肠球菌(ARHLARE)定植的发生率,遗传相关性和危险因素。在15个月内,我们纳入了105位患者。 ARHLARE定植的唯一独立危险因素是头孢噻肟/头孢曲松治疗的天数[比值比(OR):1.13; 95%置信区间(CI)1.10-1.27; P = 0.045]。总抗生素使用量较高,机械通气时间较长的患者以及尿路感染(UTI)的患者也更有可能被ARHLARE定植。脉冲场凝胶电泳表明大多数定殖菌株的多焦点起源。我们的研究结果表明,每位患者10每日定义剂量(DDD)的抗生素总消耗量增加,ARHLARE定植的几率增加36%。提出了进一步努力以优化高危患者的抗菌药物使用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号